Carregant...
Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
BACKGROUND: Rituximab is a novel chimeric monoclonal antibody that has established itself as a potent therapeutic option for autoimmune medical conditions, including systemic lupus erythematosus, owing to its mechanism of action targeting CD20 cells. Rituximab is also known to cause a spectrum of si...
Guardat en:
| Publicat a: | J Med Case Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264985/ https://ncbi.nlm.nih.gov/pubmed/34233732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02950-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|